Critical Comparison: Bioanalytical Systems (BASI) & Charles River Laboratories Intl. (CRL)

Charles River Laboratories Intl. (NYSE:CRL) and Bioanalytical Systems (NASDAQ:BASI) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, dividends, earnings, institutional ownership and profitability.

Analyst Ratings

This is a breakdown of recent recommendations for Charles River Laboratories Intl. and Bioanalytical Systems, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Charles River Laboratories Intl. 0 6 9 0 2.60
Bioanalytical Systems 0 0 0 0 N/A

Charles River Laboratories Intl. presently has a consensus target price of $133.07, indicating a potential downside of 0.41%. Given Charles River Laboratories Intl.’s higher possible upside, equities analysts plainly believe Charles River Laboratories Intl. is more favorable than Bioanalytical Systems.

Volatility & Risk

Charles River Laboratories Intl. has a beta of 0.74, suggesting that its stock price is 26% less volatile than the S&P 500. Comparatively, Bioanalytical Systems has a beta of 0.73, suggesting that its stock price is 27% less volatile than the S&P 500.

Institutional & Insider Ownership

96.2% of Charles River Laboratories Intl. shares are owned by institutional investors. Comparatively, 7.7% of Bioanalytical Systems shares are owned by institutional investors. 2.1% of Charles River Laboratories Intl. shares are owned by company insiders. Comparatively, 1.4% of Bioanalytical Systems shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares Charles River Laboratories Intl. and Bioanalytical Systems’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Charles River Laboratories Intl. 6.39% 25.08% 8.54%
Bioanalytical Systems 1.06% 4.43% 1.66%

Valuation and Earnings

This table compares Charles River Laboratories Intl. and Bioanalytical Systems’ top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Charles River Laboratories Intl. $1.86 billion 3.46 $123.35 million $5.27 25.35
Bioanalytical Systems $24.24 million 0.58 $880,000.00 N/A N/A

Charles River Laboratories Intl. has higher revenue and earnings than Bioanalytical Systems.

Summary

Charles River Laboratories Intl. beats Bioanalytical Systems on 11 of the 11 factors compared between the two stocks.

Charles River Laboratories Intl. Company Profile

Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery, non-clinical development, and safety testing services worldwide. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment produces and sells research model strains primarily genetically and microbiologically defined purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates comprising genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification of a druggable target through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, which comprise bioanalysis, pharmacokinetics, drug metabolism, toxicology, and pathology services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile biopharmaceuticals, and consumer products. It also offers specialized testing of biologics and devices that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines. The company serves pharmaceutical and biotechnology, agricultural and chemical, life science and veterinary medicine, and medical device companies; and contract research and contract manufacturing organizations, diagnostic and other commercial entities, hospitals, academic institutions, and government agencies. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.

Bioanalytical Systems Company Profile

Bioanalytical Systems, Inc. provides drug discovery and development services, and analytical instruments for pharmaceutical, biotechnology, academic, and government organizations in the United States, rest of North America, the Pacific Rim, Europe, and internationally. It operates through Contract Research Services and Research Products segments. The Contract Research Services segment offers screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing services. It also provides in vivo sampling services for the continuous monitoring of chemical changes in life; preclinical and pathology services; product characterization, method development, and validation; bioanalytical testing to measure drug and metabolite concentrations in complex biological matrices; stability testing to establish and confirm product purity, potency, and shelf life; and climate-controlled archiving services for its customers' data and samples. The Research Products segment offers analytical products comprising liquid chromatographic and electrochemical instruments with associated accessories; in vivo sampling products consisting of Culex family of automated in vivo sampling and dosing instruments; and Vetronics' products, such as instruments and related software to monitor and diagnose cardiac function, and measure other vital physiological parameters in cats and dogs in veterinary clinics. Bioanalytical Systems, Inc. was founded in 1974 and is headquartered in West Lafayette, Indiana.

Receive News & Ratings for Charles River Laboratories Intl. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Charles River Laboratories Intl. and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply